NON-HODGKIN LYMPHOMA
Clinical trials for NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental NK cell cocktail aims to outsmart resistant lymphoma
Disease control Not yet recruitingThis early-phase trial tests a combination of two antibody drugs (rituximab and tafasitamab) plus donated natural killer (NK) immune cells for people with B-cell non-Hodgkin lymphoma that has returned or not responded to at least two prior treatments. Up to 15 participants will r…
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated May 26, 2026 03:20 UTC
-
Exercise-Powered immune cells take on leukemia in first human trial
Disease control Not yet recruitingThis early study tests a new approach using donor immune cells boosted by exercise to prevent or treat leukemia relapse after a stem cell transplant. About 94 people with blood cancers will receive either standard donor cells or these exercise-mobilized cells. The goal is to see …
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: University of Arizona • Aim: Disease control
Last updated May 22, 2026 14:02 UTC